DK2739295T3 - Formuleringer omfattende saccharomyces boulardii og superoxiddismutase til bekæmpelse af fedme - Google Patents
Formuleringer omfattende saccharomyces boulardii og superoxiddismutase til bekæmpelse af fedme Download PDFInfo
- Publication number
- DK2739295T3 DK2739295T3 DK12750344.9T DK12750344T DK2739295T3 DK 2739295 T3 DK2739295 T3 DK 2739295T3 DK 12750344 T DK12750344 T DK 12750344T DK 2739295 T3 DK2739295 T3 DK 2739295T3
- Authority
- DK
- Denmark
- Prior art keywords
- obesity
- sod
- superoxide dismutase
- composition
- diet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/446—Superoxide dismutase (1.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Claims (6)
1. Sammensætning indeholdende Saccharomyces cerevisiae var boulardii og enzymet superoxiddismutase.
2. Sammensætning ifølge krav 1, hvor superoxiddismutasen er i gastrobe-skyttet form.
3. Sammensætning ifølge krav 1 eller 2 i kit-form, egnet til samtidig, separat eller sekventiel indgivelse.
4. Sammensætning ifølge krav 1,2 eller 3 til anvendelse som et kosttilskud.
5. Sammensætning ifølge krav 1 eller 2 til anvendelse ved forebyggelse eller reduktion af risikoen for at udvikle metaboliske dysfunktioner relateret til fedme.
6. Sammensætning ifølge krav 1 eller 2 til anvendelse til reduktion af vægtøgning, til reduktion af fødeindtagelse, til reduktion af ophobning af kropsfedt og til bedring af den systemiske inflammatoriske tilstand forbundet med fedme.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT001488A ITMI20111488A1 (it) | 2011-08-03 | 2011-08-03 | Formulazioni comprendenti saccharomyces boulardii e superossido dismutasi (sod) per controllare l'obesita' |
PCT/EP2012/065119 WO2013017650A2 (en) | 2011-08-03 | 2012-08-02 | Formulations containing saccharomyces boulardii and superoxide dismutase (sod) to control obesity |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2739295T3 true DK2739295T3 (da) | 2016-03-14 |
Family
ID=44675697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK12750344.9T DK2739295T3 (da) | 2011-08-03 | 2012-08-02 | Formuleringer omfattende saccharomyces boulardii og superoxiddismutase til bekæmpelse af fedme |
Country Status (25)
Country | Link |
---|---|
US (1) | US9555082B2 (da) |
EP (1) | EP2739295B1 (da) |
JP (1) | JP6126595B2 (da) |
KR (1) | KR101954674B1 (da) |
CN (1) | CN103764156A (da) |
AU (1) | AU2012292029B2 (da) |
BR (1) | BR112014001336A2 (da) |
CA (1) | CA2843794C (da) |
CY (1) | CY1117187T1 (da) |
DK (1) | DK2739295T3 (da) |
ES (1) | ES2562647T3 (da) |
GE (1) | GEP20166436B (da) |
HR (1) | HRP20160293T1 (da) |
HU (1) | HUE027121T2 (da) |
IL (1) | IL230723B (da) |
IT (1) | ITMI20111488A1 (da) |
MX (1) | MX349242B (da) |
PL (1) | PL2739295T3 (da) |
RS (1) | RS54594B1 (da) |
RU (1) | RU2600843C2 (da) |
SI (1) | SI2739295T1 (da) |
SM (1) | SMT201600086B (da) |
UA (1) | UA112990C2 (da) |
WO (1) | WO2013017650A2 (da) |
ZA (1) | ZA201400758B (da) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2870969A1 (fr) * | 2013-11-08 | 2015-05-13 | Biocodex | Composition pharmaceutique pour la réduction de la masse adipeuse |
KR101893735B1 (ko) * | 2018-05-04 | 2018-08-31 | 주식회사이-글벳 | 열 안정성이 강화된 효모를 이용한 정장효능이 있는 산제 동물용 의약품 조성물 및 그 제조 방법 |
TW202408555A (zh) * | 2022-06-29 | 2024-03-01 | 香港商香港微生物菌群創新中心有限公司 | 使用微生物治療肥胖症的方法和組合物 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62215532A (ja) * | 1986-03-18 | 1987-09-22 | Ube Ind Ltd | 抗炎症剤 |
FR2825004B1 (fr) * | 2001-05-22 | 2005-02-11 | Bio Springer | Produit dietetique satiant |
US20060008511A1 (en) * | 2004-07-08 | 2006-01-12 | Jhy-Jhu Lin | Probiotic products for pet applications |
US7935334B2 (en) * | 2005-07-07 | 2011-05-03 | Imagilin Technologies, LLC | Probiotics as alternative medicines against infectious diseases |
US20060093592A1 (en) * | 2004-10-04 | 2006-05-04 | Nutracea | Synbiotics |
SE529185C2 (sv) | 2005-10-07 | 2007-05-22 | Arla Foods Amba | Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt |
CN101172118A (zh) | 2006-07-26 | 2008-05-07 | 美国医迈科技有限公司 | 作为抗传染病替代药物的益生微生物 |
KR20080094459A (ko) * | 2007-04-20 | 2008-10-23 | 주식회사 엘지생활건강 | 항산화 활성을 갖는 화장료 조성물 |
EP2030623A1 (en) * | 2007-08-17 | 2009-03-04 | Nestec S.A. | Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria |
CN101130068B (zh) * | 2007-09-04 | 2010-05-19 | 陈坤鑫 | Sod减肥酒及其生产方法 |
MY159379A (en) * | 2007-12-26 | 2016-12-30 | Lesaffre & Cie | Composition for human and/or animal nutrition, uses thereof and yeasts |
MX2010008879A (es) * | 2008-02-14 | 2010-10-20 | Barley & Oats Co Ltd | Metodo para producir un producto fermentado usando material natural, y alimento o medicina que contiene el producto fermentado hecho a partir de el. |
US20110091553A1 (en) * | 2008-06-02 | 2011-04-21 | Kaneka Corporation | Method for producing microcapsules using solid fat |
JP2010100530A (ja) * | 2008-10-21 | 2010-05-06 | Ikeda Shokken Kk | 抗肥満剤 |
US20120027891A1 (en) * | 2009-01-14 | 2012-02-02 | Nutrafood Nutreients, Inc. | Consumable dissolving film comprising active ingredients derived from bacteria and fungi |
EP2216036A1 (en) | 2009-02-10 | 2010-08-11 | Nestec S.A. | Lactobacillus rhamnosus NCC4007, a probiotic mixture and weight control |
EP3181134B1 (en) | 2009-06-19 | 2019-10-30 | DuPont Nutrition Biosciences ApS | Bifidobacteria for treating diabetes and related conditions |
JP2011004640A (ja) * | 2009-06-24 | 2011-01-13 | Kaneka Corp | 魚介エキスの精製方法 |
RU2012107695A (ru) * | 2009-07-31 | 2013-09-10 | Нестек С.А. | Питательная композиция для вскармливаемых грудью детей или домашних животных с пробиотиками и подобранными питательными веществами |
IT1396074B1 (it) * | 2009-10-12 | 2012-11-09 | Axioma S R L | Composizione ad attivita' termogenetica potenziata e suo impiego nella prevenzione e trattamento dell'obesita' |
-
2011
- 2011-08-03 IT IT001488A patent/ITMI20111488A1/it unknown
-
2012
- 2012-02-08 UA UAA201400940A patent/UA112990C2/uk unknown
- 2012-08-02 KR KR1020147002623A patent/KR101954674B1/ko active IP Right Grant
- 2012-08-02 CN CN201280038195.8A patent/CN103764156A/zh active Pending
- 2012-08-02 SI SI201230479T patent/SI2739295T1/sl unknown
- 2012-08-02 HU HUE12750344A patent/HUE027121T2/en unknown
- 2012-08-02 BR BR112014001336A patent/BR112014001336A2/pt not_active Application Discontinuation
- 2012-08-02 MX MX2014001327A patent/MX349242B/es active IP Right Grant
- 2012-08-02 PL PL12750344T patent/PL2739295T3/pl unknown
- 2012-08-02 ES ES12750344.9T patent/ES2562647T3/es active Active
- 2012-08-02 RU RU2014103483/15A patent/RU2600843C2/ru active
- 2012-08-02 JP JP2014523329A patent/JP6126595B2/ja active Active
- 2012-08-02 US US14/235,188 patent/US9555082B2/en active Active
- 2012-08-02 GE GEAP201213368A patent/GEP20166436B/en unknown
- 2012-08-02 CA CA2843794A patent/CA2843794C/en active Active
- 2012-08-02 AU AU2012292029A patent/AU2012292029B2/en active Active
- 2012-08-02 DK DK12750344.9T patent/DK2739295T3/da active
- 2012-08-02 RS RS20160146A patent/RS54594B1/en unknown
- 2012-08-02 EP EP12750344.9A patent/EP2739295B1/en active Active
- 2012-08-02 WO PCT/EP2012/065119 patent/WO2013017650A2/en active Application Filing
-
2014
- 2014-01-30 IL IL230723A patent/IL230723B/en active IP Right Grant
- 2014-01-31 ZA ZA2014/00758A patent/ZA201400758B/en unknown
-
2016
- 2016-02-15 CY CY20161100122T patent/CY1117187T1/el unknown
- 2016-03-22 HR HRP20160293TT patent/HRP20160293T1/hr unknown
- 2016-03-24 SM SM201600086T patent/SMT201600086B/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Singh et al. | Lactobacillus rhamnosus NCDC17 ameliorates type-2 diabetes by improving gut function, oxidative stress and inflammation in high-fat-diet fed and streptozotocintreated rats | |
KR102297388B1 (ko) | 대사장애를 치료하기 위한 아커만시아의 용도 | |
CN111971056A (zh) | 用于治疗和缓解代谢及氧化应激、炎症和神经退行性变的益生菌制剂 | |
EP2870234B1 (fr) | Nouvelle souche de lactobacillus crispatus | |
EP2650002A1 (en) | Bifidobacterium cect 7765 and use thereof in the prevention and/or treatment of excess weight, obesity and related pathologies | |
PT2236598E (pt) | Microrganismos para melhorar o estado de saúde de indivíduos com distúrbios relacionados com a ingestão de glúten | |
Wang et al. | Bifidobacterium longum relieves constipation by regulating the intestinal barrier of mice | |
Russo et al. | Oral administration of Lactobacillus fermentum CRL1446 improves biomarkers of metabolic syndrome in mice fed a high-fat diet supplemented with wheat bran | |
US10022407B2 (en) | Use of a lactobacillus rhamnosus strain for reducing weight gain and/or insulin resistance | |
Sheykhsaran et al. | Gut microbiota and obesity: an overview of microbiota to microbial-based therapies | |
Tang et al. | Nuciferine administration in C57BL/6J mice with gestational diabetes mellitus induced by a high-fat diet: The improvement of glycolipid disorders and intestinal dysbacteriosis | |
DK2739295T3 (da) | Formuleringer omfattende saccharomyces boulardii og superoxiddismutase til bekæmpelse af fedme | |
Arellano-García et al. | Lactobacillus rhamnosus GG administration partially prevents diet-induced insulin resistance in rats: a comparison with its heat-inactivated parabiotic | |
JP2022506081A (ja) | ラクトバチルス(lactobacillus)を含む代謝的健康のためのプロバイオティクス補助食品 | |
NZ620579B2 (en) | Formulations comprising saccharomyces boulardii and superoxide dismutase for controlling obesity | |
Westfall | Development of a novel probiotic and synbiotic formulation for the management of neurodegenerative and other diseases | |
Velykaya et al. | Probiotics: their influence on the inflammatory processes and other cardiovascular disease factors | |
Yonejima | Health-promoting effects of lactic acid bacteria and probiotics: Their antiobesity and lipid lowering effects |